Evidence map›Paper›PMID 37387287›Full record

ArticleeLife2023

Long-range DNA end resection supports homologous recombination by checkpoint activation rather than extensive homology generation.

Michael T Kimble, Matthew J Johnson, Mattie R Nester, Lorraine S Symington

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Michael T KimbleProgram in Biological Sciences, Columbia University, New York, United States.ORCID 0000-0001-8042-2868
Matthew J JohnsonProgram in Biological Sciences, Columbia University, New York, United States.ORCID 0000-0002-4312-5618
Mattie R NesterDepartment of Microbiology & Immunology, Columbia University Irving Medical Center, New York, United States.
Lorraine S SymingtonDepartment of Microbiology & Immunology, Columbia University Irving Medical Center, New York, United States.ORCID 0000-0002-1519-4800
Columbia University · USColumbia University Irving Medical Center · US

Funding

CELLULAR AND MOLECULAR FOUNDATIONS OF BIOMEDICAL SCIENCET32GM008798 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI PRYWES, RON M · 2001 to 2018
$6.3M
Mechanism and regulation of DNA double-strand break repairR35GM126997 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Lorraine S Symington · 2018 to 2026
$5.9M
Genome and Epigenome Integrity In CancerT32CA265828 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Alberto Ciccia, Chao Lu · 2022 to 2026
$1.8M
NCI NIH HHS T32 CA265828NIGMS NIH HHS R35 GM126997NIGMS NIH HHS T32 GM008798
6 · The paper itself

Abstract

Homologous recombination (HR), the high-fidelity mechanism for double-strand break (DSB) repair, relies on DNA end resection by nucleolytic degradation of the 5'-terminated ends. However, the role of long-range resection mediated by Exo1 and/or Sgs1-Dna2 in HR is not fully understood. Here, we show that Exo1 and Sgs1 are dispensable for recombination between closely linked repeats, but are required for interchromosomal repeat recombination in

Indexed as

Saccharomyces cerevisiae ProteinsDNADNA Breaks, Double-StrandedDNA RepairExodeoxyribonucleasesHomologous RecombinationRecQ HelicasesSaccharomyces cerevisiaeDNAExodeoxyribonucleasesRecQ HelicasesSaccharomyces cerevisiae ProteinscheckpointDNA repairExo1geneticsgenomicshomologous recombinationS. cerevisiaeSgs1

Identifiers

PMID37387287
PMCPMC10400078
OpenAlexW4382630740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.